SCHEMBL20547246

SCHEMBL20547246

CCOC(=O)N1CCc2noc(-c3ccccc3Cl)c2CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 4/20 0.49
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 1/20 0.45
LMNA P02545 4/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
MAPT P10636 1/20 0.43
HRH1 P35367 1/20 0.42
EPAS1 Q99814 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 1/20 0.41
ALOX15 P16050 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547293 0.89 NPC1 (0.54) NPC1RAB9AKMT2AALDH1A1LMNA
SCHEMBL20547245 0.87 NPC1 (0.53) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL20547218 0.84 KMT2A (0.51) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL20547362 0.82 SMN1; SMN2 (0.53) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL20547285 0.81 KCNH2 (0.56) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL20546709 0.80 LMNA (0.51) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL20547359 0.78 DPP4 (0.48) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL20547217 0.78 LMNA (0.47) NPC1RAB9AKMT2AMEN1LMNA
SCHEMBL20547288 0.77 LMNA (0.50) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL10143953 0.74 KMT2A (0.73) NPC1RAB9AKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A NPC1 4051/4885RAB9A 1748/4885KMT2A 2474/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A NPC1 4051/4885RAB9A 1748/4885KMT2A 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.